January 01, 2021

Worthington Announces the Availability of the New 2021-22 Enzyme and Biochemical Digital Catalog

Catalog features new products and updated technical resources.

LAKEWOOD, NJ (January 1, 2021) – Worthington announced today the release of the new 2021 - 2022 Enzyme and Biochemical Digital Catalog for biochemistry, cell biology, molecular biology, neuroscience and bioprocessing applications.

As a specialty life science enzyme company with a solid 75-year history, the Worthington name has become synonymous with the term “primary producer”. New products highlighted in the guide include
 recombinant Proteinase K.

“We are proud to release our new digital catalog focusing on cell and molecular biology, tissue dissociation and protein research,” said Jim Zacka, vice president at Worthington. “With COVID restrictions preventing our account representatives from seeing researchers in the lab, this digital format allows us to keep our customers abreast of new developments in our specialty enzyme and related biochemical product lines.”

About Worthington Biochemical Corporation

Founded in 1947, Worthington Biochemical Corporation is an industry leader in the development and production of high-quality purified enzymes, proteins, nucleic acids and cell isolation kits for life science research, diagnostics and biotechnology applications. An ISO9001 Certified, primary manufacturer Worthington meets enzyme requirements from research to large-scale bulk bioprocessing and OEM applications. Worthington Biochemical Corporation is a privately held company, headquartered in Lakewood, NJ and has worldwide distribution through a network of distributors.

For more information, contact: marketing@worthington-biochem.com

January 01, 2021